PET imaging for inflammatory cardiac diseases is advancing with new hardware and radiotracers, supporting its utility for diagnosis, treatment monitoring, and risk stratification.
Recent advances in PET imaging hardware and radiotracers expand its utility in inflammatory cardiac diseases beyond diagnosis to treatment monitoring and risk stratification.
F]FDG)-based approach toward a broader molecular imaging platform that combines technical innovation with tracer diversification. This review summarizes recent advances in PET imaging of inflammatory cardiac disease, including new hardware and promising new radiotracers. Current evidence supports PET as a tool not only for diagnosis but also for treatment monitoring and risk stratification, and future progress will depend on standardization, histologic validation, and integration of advanced hardware, disease-specific tracers, and multimodality biomarkers into clinically actionable pathways.
Bund et al. (2026) conducted a review in Inflammatory cardiac diseases. PET imaging was evaluated. PET imaging for inflammatory cardiac diseases is advancing with new hardware and radiotracers, supporting its utility for diagnosis, treatment monitoring, and risk stratification.